1. Home
  2. PRIM vs GPCR Comparison

PRIM vs GPCR Comparison

Compare PRIM & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primoris Services Corporation

PRIM

Primoris Services Corporation

SELL

Current Price

$84.63

Market Cap

4.6B

Sector

Industrials

ML Signal

SELL

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

BUY

Current Price

$27.17

Market Cap

3.8B

Sector

N/A

ML Signal

BUY

Company Overview

Basic Information
Metric
PRIM
GPCR
Founded
1960
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
3.8B
IPO Year
2006
2023

Fundamental Metrics

Financial Performance
Metric
PRIM
GPCR
Price
$84.63
$27.17
Analyst Decision
Buy
Strong Buy
Analyst Count
16
16
Target Price
★ $117.80
$105.78
AVG Volume (30 Days)
1.1M
★ 1.2M
Earning Date
11-02-2026
11-05-2026
Dividend Yield
★ 0.38%
N/A
EPS Growth
★ 51.66
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$11.32
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$65.00
$25.59
52 Week High
$205.50
$94.90

Technical Indicators

Market Signals
Indicator
PRIM
GPCR
Relative Strength Index (RSI) 66.47 17.84
Support Level $70.54 N/A
Resistance Level $85.60 $56.63
Average True Range (ATR) 3.41 1.92
MACD 1.21 -0.63
Stochastic Oscillator 82.87 5.99

Price Performance

Historical Comparison
PRIM
GPCR

About PRIM Primoris Services Corporation

Primoris Services Corp is a provider of critical infrastructure services operating mainly in the United States and Canada. The company provides a range of construction, maintenance, replacement, and engineering services. The Utilities segment operates throughout the United States and specializes in a range of services, including the construction and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communications systems. The Energy segment operates throughout the United States and Canada and specializes in a range of services that include engineering, procurement, construction, and maintenance services to various industries. The majority of the company's revenue is derived from the Energy segment.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: